- Title
- Treatment of High-Risk Biochemically Recurrent Prostate Cancer with Enzalutamide in Combination with Leuprolide: Secondary End Points from the EMBARK Trial: Erratum
- Creators
- Neal D ShoreMartin GleaveUgo De GiorgiAntti RannikkoChristopher M PieczonkaSwetha SridharanKlaus BrassoHenry H WooAntonio Gómez CaamañoJeff W SaranchukLuke T NordquistUbirajara FerreiraYiyun TangBrad RosbrookGabriel P HaasMatt RosalesFabian ZohrenJamal TaraziStephen J Freedland
- Publication Details
- The Journal of urology, Vol.216(2), p.311
- Identifiers
- 991006290773902656
- Academic Unit
- Radiology
- Language
- English
- Resource Type
- Journal article
Journal article
Treatment of High-Risk Biochemically Recurrent Prostate Cancer with Enzalutamide in Combination with Leuprolide: Secondary End Points from the EMBARK Trial: Erratum
The Journal of urology, Vol.216(2), p.311
08/01/2026
PMID: 42423152
Metrics
1 Record Views